Primary Tumor Location May Not Predict Nonmetastatic CRC Outcomes Primary Tumor Location May Not Predict Nonmetastatic CRC Outcomes

In patients with stage 3 colon cancer, primary tumor location (PTL) - according to BRAF and RAS mutations, and microsatellite instability (MSI) status - showed no prognostic value in a post hoc analysis of data from the PETACC-8 study.Reuters Health Information
Source: Medscape Pathology Headlines - Category: Pathology Tags: Hematology-Oncology News Source Type: news